Richard Hovis: Help Sean Zahul in his battle against recurrent medulloblastoma
Richard Hovis, Full time Caregiver, shared a post on Bluesky:
“Please Help Sean Zahul in his battle against recurrent medulloblastoma. He has been fighting this Cancer for over 2 years now.
Sean is at a critical junction. Aetna Is refusing coverage of his next cycle. At a cost 36k /month. Please help, follow the link.
Metastatic High-Risk Recurrent Medulloblastoma Is a very Rare Brain Cancer for Adults less than 200 adults in the US are diagnosed per year.
Because of this rarety treatment is considered experimental. We need your help.
This is Sean!
Sean needs everyones help to beat Cancer.
Aetna is denying Sean’s next chemo protocol.
200mg capsule in a 30-count bottle: Average wholesale price (AWP) of $12,072.
Please do not turn your back on Sean.
You can make a difference.”
More posts featuring Richard Hovis.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023